UCB - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Alcon AG USD 21.6B 538M 2026-06
Almirall EUR 1.53B 43.26M 2026-06
Amarin USD 444.41M 796K 2026-09
argenx SE USD 8.42B 1.09B 2026-06
AstraZeneca USD 51.73B 1.43B 2026-09
Bayer EUR 29.18B 533M 2026-09
Genmab DKK 5.96B 275M 2026-06
GlaxoSmithKline GBP 18.75B 1.11B 2026-09
GRIFOLS EUR 5.79B 2.19B 2026-09
Hikma Pharmaceutical USD 2.59B 42M 2025-12
Lakefront Biotherapeutics EUR 3.26B 10.26M 2026-06
Lonza CHF 9.13B 513M 2025-12
Merck EUR 31.34B 1.16B 2026-09
Novartis USD 37.23B 4.72B 2026-09
Orion EUR 1.4B 129.5M 2026-09
Recordati EUR 2.34B 209.24M 2026-09
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 72.88B 3.31B 2026-09
UCB EUR 10.87B 1.18B 2025-12
Unibail Rodamco EUR 15.9B 559M 2025-12